This is according to the latest ‘Integrated Vaccination Management’ report GIVCOVID19 published by the Ministry of Health, which includes data on the development of the campaign up to Wednesday, 9 November.
In total, 4,631,612 people over the age of 60 have already received this second booster with vaccines adapted to the sublineages of the Omicron variant of the SAR-CoV-2 virus.
In addition to the 1,732,297 people aged 80 and over who have received this second booster, 1,639,575 people aged between 70 and 79 (more than 41%) and 1,259,740 people aged between 60 and 69 (almost 23%) have also received this second booster dose, bringing the coverage rate among people over 60 to 37.4%.
The vaccination campaign with a second booster dose began on 26 September in all the autonomous communities and cities and, until the end of the year, Spain will receive 44 million adapted vaccines from Pfizer and Moderna for the campaign.
According to the agreement reached by the Public Health Commission, the initial target groups for this campaign are people over 80 years of age and people living in old people’s homes, and subsequently health and social-health personnel, people over 60 years of age and people who have not completed their immunisation.
Currently, 92.2% of the population over 60 years of age has already received the first booster dose of COVID-19: 11,418,493 people.
Spain is one of the world’s leading countries in terms of vaccination. Since the start of the first COVID-19 vaccination campaign on 27 December 2020, milestones have been gradually reached in this area.
Spain was the first country to vaccinate 100% of its population over 80 years of age and has high vaccination coverage rates: 92.8% of people over 12 years of age with a complete vaccination schedule (more than 39.1 million inhabitants) and 80% of people over 40 years of age with a booster dose.
Spain has also made 70 million doses of SARS-CoV-2 vaccine available to third countries, making it one of the top 10 countries in the world with the highest effective donation through the COVAX mechanism.